{"id":"topical-diclofenac-gel-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Local skin irritation or rash at application site"},{"rate":null,"effect":"Photosensitivity"},{"rate":null,"effect":"Gastrointestinal upset (if systemically absorbed)"}]},"_chembl":null,"_dailymed":{"setId":"a133d18e-981d-43b7-bef1-7869f7c7d9a7","title":"DICLOFENAC SODIUM (DICLOFENAC SODIUM TOPICAL GEL, 1%) GEL [SPORTPHARM LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Diclofenac blocks COX-1 and COX-2 enzymes, which are responsible for producing prostaglandins that mediate inflammation, pain, and fever. When applied topically as a gel, it penetrates the skin to reach underlying tissues and joints, providing localized anti-inflammatory and analgesic effects with reduced systemic exposure compared to oral formulations.","oneSentence":"Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of application.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T06:29:20.750Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Topical relief of pain and inflammation associated with osteoarthritis and other musculoskeletal conditions"}]},"trialDetails":[{"nctId":"NCT07475663","phase":"PHASE3","title":"Counterpain PXM Versus Diclofenac Versus Piroxicam","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Indonesia","startDate":"2025-11-04","conditions":"Ankle Sprain, Back Pain, Osteoarthritis (OA) of the Knee","enrollment":180},{"nctId":"NCT07079969","phase":"PHASE2","title":"Effects of Photobiomodulation and Topical Diclofenac on Inflammation and Pain in Knee Osteoarthritis (EPIC-KO)","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-04","conditions":"Knee Pain Chronic","enrollment":32},{"nctId":"NCT06729073","phase":"PHASE1","title":"Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.","status":"COMPLETED","sponsor":"Amzell","startDate":"2024-11-29","conditions":"Healthy Volunteer","enrollment":34},{"nctId":"NCT07060976","phase":"NA","title":"To Check Dermatological Safety of Test Products by 24 Hours Patch Testing","status":"COMPLETED","sponsor":"Novamed Laboratories Pvt. Ltd.","startDate":"2025-07-21","conditions":"Healthy Participants","enrollment":26},{"nctId":"NCT07177560","phase":"","title":"Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)","status":"COMPLETED","sponsor":"Gazi University","startDate":"2023-07-30","conditions":"Colorectal Cancer, Gastric Cancer (GC), Capecitabine","enrollment":151},{"nctId":"NCT05877027","phase":"NA","title":"Exercise vs. Topical Diclofenac vs. PRP","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2024-03-20","conditions":"Gonarthrosis","enrollment":82},{"nctId":"NCT05882812","phase":"PHASE2","title":"Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2023-06-03","conditions":"Osteo Arthritis Knee, Arthritis","enrollment":200},{"nctId":"NCT05050448","phase":"PHASE1, PHASE2","title":"Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2021-08-01","conditions":"Knee Osteoarthritis","enrollment":60},{"nctId":"NCT05968482","phase":"PHASE1","title":"Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Participants","status":"COMPLETED","sponsor":"Amzell","startDate":"2023-07-11","conditions":"Healthy","enrollment":74},{"nctId":"NCT06574191","phase":"NA","title":"The Effects of Patient and Visit Characteristics on Health Outcomes in Knee Osteoarthritis","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2025-01-29","conditions":"Knee Osteoarthritis","enrollment":220},{"nctId":"NCT06510062","phase":"PHASE1","title":"Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2024-07-22","conditions":"Measurement of Circulation on Anatomical Locations of the Body","enrollment":67},{"nctId":"NCT06257537","phase":"PHASE2","title":"Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2024-10-01","conditions":"Osteo Arthritis Knee, Arthritis","enrollment":300},{"nctId":"NCT05883241","phase":"PHASE1","title":"Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2023-06-01","conditions":"Bone Fracture, Fresh Fracture","enrollment":90},{"nctId":"NCT05254574","phase":"PHASE1","title":"Sustained Acoustic Medicine for Osteoarthritis Pain","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2022-02-14","conditions":"Osteoarthritis","enrollment":200},{"nctId":"NCT05312645","phase":"PHASE3","title":"Diclofenac Gel in the Treatment of Cervicogenic Headache","status":"WITHDRAWN","sponsor":"Loma Linda University","startDate":"2023-12","conditions":"Cervicogenic Headache","enrollment":""},{"nctId":"NCT05026320","phase":"PHASE2","title":"A Clinical Trial to Compare Safety and Effectiveness for Relieving Tenderness of 10% Naproxen Gel vs. a 2.32% Diclofenac Diethylamine Gel in the Treatment of Strains and Bruises of the Legs.","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-08-08","conditions":"Soft Tissue Injury","enrollment":76},{"nctId":"NCT04611529","phase":"PHASE4","title":"Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2021-03-02","conditions":"Low Back Pain","enrollment":198},{"nctId":"NCT04766996","phase":"PHASE4","title":"PROUD Study - Preventing Opioid Use Disorders","status":"TERMINATED","sponsor":"Emory University","startDate":"2021-05-17","conditions":"Anesthesia, Opioid Use","enrollment":57},{"nctId":"NCT04592016","phase":"NA","title":"Evaluate the Ability of dOFM for BE Testing of Topically Applied Diclofenac Sodium Products in Healthy Subjects","status":"COMPLETED","sponsor":"Joanneum Research Forschungsgesellschaft mbH","startDate":"2020-10-08","conditions":"Healthy","enrollment":22},{"nctId":"NCT03172780","phase":"PHASE3","title":"A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee\"","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Private Limited","startDate":"2017-05-24","conditions":"Osteoarthritis, Knee","enrollment":1220},{"nctId":"NCT02121002","phase":"PHASE3","title":"Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Amneal Pharmaceuticals, LLC","startDate":"2014-04","conditions":"Osteoarthritis","enrollment":1176},{"nctId":"NCT02913521","phase":"PHASE3","title":"Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%","status":"COMPLETED","sponsor":"Akorn, Inc.","startDate":"2015-06","conditions":"Osteoarthritis, Knee","enrollment":934},{"nctId":"NCT02666846","phase":"PHASE1","title":"Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model","status":"COMPLETED","sponsor":"Futura Medical Developments Ltd.","startDate":"2015-03","conditions":"Pain","enrollment":60},{"nctId":"NCT04402047","phase":"NA","title":"Electroacupuncture vs Topical Diclofenac Sodium Gel for Patients With Hand Osteoarthritis","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2020-09-01","conditions":"Hand Osteoarthritis","enrollment":108},{"nctId":"NCT04341402","phase":"PHASE2","title":"Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study","status":"UNKNOWN","sponsor":"William N Handelman","startDate":"2020-05-01","conditions":"Tinea Unguium, Onychomycosis","enrollment":30},{"nctId":"NCT04270968","phase":"NA","title":"Shock Wave Therapy On Cervical Pain Following Neck Dissection Surgery","status":"COMPLETED","sponsor":"Qassim University","startDate":"2018-11-03","conditions":"Pain, Cervical Pain","enrollment":46},{"nctId":"NCT03020368","phase":"NA","title":"Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint","status":"TERMINATED","sponsor":"Charite University, Berlin, Germany","startDate":"2017-01","conditions":"Rhizarthrosis","enrollment":52},{"nctId":"NCT02100670","phase":"PHASE3","title":"A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-11-01","conditions":"Pain","enrollment":385},{"nctId":"NCT02201238","phase":"PHASE1","title":"Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-10-01","conditions":"Pain","enrollment":18},{"nctId":"NCT02596451","phase":"PHASE3","title":"To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2015-08","conditions":"Osteoarthritis","enrollment":1164},{"nctId":"NCT02290821","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries","status":"COMPLETED","sponsor":"Novartis","startDate":"2014-12","conditions":"Acute Blunt Soft Tissue Injuries/Contusions","enrollment":215},{"nctId":"NCT00601640","phase":"PHASE2","title":"Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2007-01","conditions":"Other Benign Neoplasm of Skin, Unspecified","enrollment":184},{"nctId":"NCT02271854","phase":"PHASE3","title":"A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness","status":"COMPLETED","sponsor":"Novartis","startDate":"2014-10","conditions":"Muscle Soreness","enrollment":102},{"nctId":"NCT00171665","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-05","conditions":"Osteoarthritis","enrollment":360},{"nctId":"NCT01454791","phase":"PHASE4","title":"Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate","status":"COMPLETED","sponsor":"Brown, Theodore R., M.D., MPH","startDate":"2011-01","conditions":"Multiple Sclerosis","enrollment":40},{"nctId":"NCT01202799","phase":"PHASE1","title":"Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2010-09","conditions":"Pain","enrollment":30},{"nctId":"NCT02068859","phase":"PHASE3","title":"Treatment of Knee Pain With Topical Diclofenac Cream 8% or Diclofenac Gel 1%","status":"UNKNOWN","sponsor":"FPR Specialty Pharmacy","startDate":"2014-01","conditions":"Knee Pain Chronic, Knee Injuries","enrollment":106},{"nctId":"NCT01272934","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain","status":"COMPLETED","sponsor":"Novartis","startDate":"2011-01","conditions":"Acute Ankle Sprain","enrollment":205},{"nctId":"NCT01272947","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries","status":"COMPLETED","sponsor":"Novartis","startDate":"2011-01","conditions":"Acute Blunt Soft Tissue Injuries/Contusions","enrollment":204},{"nctId":"NCT01255423","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain","status":"COMPLETED","sponsor":"Novartis","startDate":"2010-11","conditions":"Ankle Sprain","enrollment":206},{"nctId":"NCT01456611","phase":"PHASE3","title":"Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%","status":"COMPLETED","sponsor":"Anchen Pharmaceuticals, Inc","startDate":"2011-09","conditions":"Osteo Arthritis of the Knee","enrollment":749},{"nctId":"NCT00171691","phase":"PHASE3","title":"Safety of Diclofenac Sodium Gel in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-10","conditions":"Osteoarthritis","enrollment":450},{"nctId":"NCT00171678","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-10","conditions":"Osteearthritis","enrollment":480},{"nctId":"NCT00171626","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-08","conditions":"Osteoarthritis","enrollment":480},{"nctId":"NCT00426621","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-11","conditions":"Osteoarthritis of the Knee","enrollment":420},{"nctId":"NCT00377806","phase":"PHASE4","title":"Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins","status":"COMPLETED","sponsor":"Novartis","startDate":"2003-01","conditions":"Superficial Thrombophlebitis of the Upper Limb","enrollment":200},{"nctId":"NCT00441051","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-11","conditions":"Sunburn","enrollment":45},{"nctId":"NCT00171652","phase":"PHASE3","title":"Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-05","conditions":"Osteoarthritis","enrollment":360}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Topical Diclofenac gel 1%","genericName":"Topical Diclofenac gel 1%","companyName":"University of California, Davis","companyId":"university-of-california-davis","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of application. Used for Topical relief of pain and inflammation associated with osteoarthritis and other musculoskeletal conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}